Clinical Research Directory
Browse clinical research sites, groups, and studies.
Application of QDSA Platform in Cerebrovascular Diseases
Sponsor: Beijing Tiantan Hospital
Summary
Cerebrovascular diseases pose a major global public health challenge, characterized by exceptionally high mortality and disability rates, with their pathogenesis closely linked to hemodynamic abnormalities. The quantitative digital subtraction angiography (QDSA) analysis platform, leveraging its advantages of vessel modeling-free operation, high computational efficiency, and DSA-equivalent sensitivity, has emerged as a novel hemodynamic assessment method with significant clinical potential. This study aims to establish a cerebrovascular disease cohort incorporating QDSA parameters to systematically validate the clinical value of this technology in preoperative evaluation and surgical planning, thereby providing evidence-based insights for optimizing diagnostic and therapeutic strategies.
Official title: Research on the Application of Quantitative Digital Subtraction Angiography Hemodynamic Analysis Platform in Cerebrovascular Diseases
Key Details
Gender
All
Age Range
1 Year - 80 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-04
Completion Date
2030-02
Last Updated
2025-03-30
Healthy Volunteers
No
Conditions
Interventions
QDSA (Quantitative Digital Subtraction Angiography)
QDSA is a quantitative analysis technology based on DSA, used to assess hemodynamic characteristics and provide critical data support for the diagnosis and treatment of cerebrovascular diseases.
Locations (1)
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China